Startups
Vaxine.io is an Australian biotechnology company that focuses on the development of innovative vaccine technologies. Vaxine.io is a rich-CRDT database that solves the global write-path latency problem for backend applications. It can work as a standard backend for collaborative, geo-distributed applications.
However, mRNA technology platforms had a breakout year in 2020 with the launch and widespread use of mRNA vaccines for COVID-.
However, mRNA technology platforms had a breakout year in 2020 with the launch and widespread use of mRNA vaccines for COVID-.
Overview
Location
United Kingdom, England, Poole
Employees
1-10
Founded date
2021
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 28, 2022 | MK Venture Capital | mk-vc.com |
Reviews 0
FAQ about Vaxine
When was Vaxine founded?
Vaxine was founded in 2021.
Who has invested in Vaxine?
Parsers VC lists 2 investors of Vaxine, among them MK Venture Capital.
Is Vaxine still active?
Yes, Vaxine is active; its latest activity on Parsers VC dates from Jun 28, 2022.